JNJ-37822681 dihydrochloride
CAS No. 2108806-02-4
JNJ-37822681 dihydrochloride ( —— )
产品货号. M26266 CAS No. 2108806-02-4
JNJ-37822681 dihydrochloride is a novel, highly selective dopamine D? receptor antagonist characterized by a rapid dissociation rate from the dopamine D? receptor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥940 | 有现货 |
|
10MG | ¥1320 | 有现货 |
|
25MG | ¥2187 | 有现货 |
|
50MG | ¥3224 | 有现货 |
|
100MG | ¥4803 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称JNJ-37822681 dihydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述JNJ-37822681 dihydrochloride is a novel, highly selective dopamine D? receptor antagonist characterized by a rapid dissociation rate from the dopamine D? receptor.
-
产品描述JNJ-37822681 dihydrochloride is a novel, highly selective dopamine D? receptor antagonist characterized by a rapid dissociation rate from the dopamine D? receptor. JNJ-37822681 dihydrochloride shows a moderate binding affinity for the dopamine D2L receptor with a Ki of 158 nM.(In Vivo):JNJ-37822681 dihydrochloride occupied D2 receptors in rat brain at relatively low doses (ED50 = 0.39 mg/kg) and was effective in animal models of psychosis (e.g., inhibition of apomorphine-induced stereotypy or D-amphetamine/phencyclidine-induced hyperlocomotion).
-
同义词——
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体HBV
-
研究领域——
-
适应症——
化学信息
-
CAS Number2108806-02-4
-
分子量445.3
-
分子式C17H19Cl2F5N4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.Cl.Fc1ccc(CN2CCC(CC2)Nc2ccc(nn2)C(F)(F)F)cc1F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Danni Colledge, et al. The Novel Antiviral Agent Inarigivir Inhibits Both Nucleos(t)ide Analogue and Capsid Assembly Inhibitor Resistant HBV in vitro.
产品手册
关联产品
-
GSK598809
GSK598809 (GSK-598809) is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.
-
Gemcitabine monophos...
Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
-
GR 103691
GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).?